Investor Presentaiton
Favorable Demographic and Macroeconomic Trends
Brazilian Population above
(Million of people)
60 years old
CAGR 00-10 = 3.3%
CAGR 10-30 3.8%
13.9
2000
19.3
2010
28.3
+
Annual per Capita Pharma Spending
Selected Countries
Products Losing Patents*
2010 to 2012
(US$ in 2009)
40.5
USA
France
655
Japan
635
Germany
Argentina
142
Brazil
68
99
2020
2030
% of Total Population
Mexico
65
8.1%
10.0%
13.7%
18.7%
Source: IMS Health
512
988
50
Molecules Exposed
to Generics
US$ 500MM
Total Demand
*Lipitor (Pfizer), Viagra (Pfizer), Diovan (Novartis), Crestor
(Astra Zeneca), Atacand (Astra Zeneca), Zyprexa (Lilly),
Seroquel (Astra Zeneca), Singulair (MSD), Micardis
(Boehringer), Benicar (Sankyo), Aprozide (Sanofi), Aprovel
(Sanofi), Others
Source: IMS Health, Population Reference Bureau 2009
Source: IMS Health
14View entire presentation